# NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma

> **NCT07211737** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Baylor College of Medicine** · enrollment: 27 (estimated)

## Conditions studied

- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Relapsed Osteosarcoma
- Refractory Osteosarcoma

## Interventions

- **GENETIC:** i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells
- **GENETIC:** i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells
- **GENETIC:** i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells

## Key facts

- **NCT ID:** NCT07211737
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-04
- **Final completion:** 2044-04
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211737, "NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07211737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*